We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Therapeutic Delivery – Products

Distinguishing Oxidative Impurities From Ionizable Lipids Using Electron Activated Dissociation content piece image
App Note / Case Study

Distinguishing Oxidative Impurities From Ionizable Lipids Using Electron Activated Dissociation

Lipid nanoparticles (LNPs) comprised of ionizable lipids can be used to deliver oligonucleotides to work as therapeutics or to stimulate the immune system. Detailed and sensitive characterization of the ionizable lipid and its related impurities is necessary to ensure quality, however, obtaining the level of detail needed is challenging with current LC-MS-based methodologies.
Exosomes being produced by a large cell
Product News

Highly Characterized, High Purity Exosome Standards

AMSBIO offer an extensive range of highly characterized, high purity exosomes for use as control standards in applications including marker assessment, immunocapture performance evaluation, exosome quantification, OMICS analysis, flow cytometry and electron microscopy.
Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis content piece image
Product News

Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis

Waters Corporation today announced expanded powder rheology capabilities for its TA Instruments HR Rheometers allowing scientists to make repeatable powder rheology measurements.
CapnoPharm Awarded as Drug Delivery Platform Capnodrug® Reaches Finals of Reuters Pharma Europe Award 2022 content piece image
Product News

CapnoPharm Awarded as Drug Delivery Platform Capnodrug® Reaches Finals of Reuters Pharma Europe Award 2022

CapnoPharm is proud to announce its selection as a finalist of the prestigious Reuters Pharma Europe Award 2022 for its Cancer drug delivery innovation - Capnodrug® - in the Health Entrepreneur Award category.
Gene Modification for Cell Therapy Applications content piece image
App Note / Case Study

Gene Modification for Cell Therapy Applications

The clinical success of CAR T-cell therapy has spurred increased interest and investments in the advanced therapeutics industry.
TetraScience Launches Revolutionary Scientific Data Cloud content piece image
Product News

TetraScience Launches Revolutionary Scientific Data Cloud

TetraScience has announced the evolution of its data cloud to include manufacturing and quality control data.
Biotium Introduces New Line of Antibodies for Exosome Detection content piece image
Product News

Biotium Introduces New Line of Antibodies for Exosome Detection

Biotium has announced the release of new ExoBrite Antibody Conjugates. These antibodies were curated specifically for optimal detection of exosome markers CD9, CD63 and CD81 in isolated exosomes or exosome extracts with little to no background.
MaxCyte Signs Strategic Platform License With LG Chem To Advance its Allogeneic CAR-T Programs content piece image
Product News

MaxCyte Signs Strategic Platform License With LG Chem To Advance its Allogeneic CAR-T Programs

MaxCyte, Inc. has announced the signing of a strategic platform license with LG Chem Ltd.
Analysis of Lipid Nanoparticle Composition content piece image
App Note / Case Study

Analysis of Lipid Nanoparticle Composition

In recent years, interest in lipid nanoparticle (LNP) research has increased due to promising opportunities for RNA-based therapy and gene-editing technology, and LNPs are showing promise as nucleic acid delivery vehicles in the pharmaceutical industry.
Vaccizone Selects Exothera for Process Development and GMP Manufacturing of its SARS-CoV-2 Vaccine content piece image
Product News

Vaccizone Selects Exothera for Process Development and GMP Manufacturing of its SARS-CoV-2 Vaccine

Vaccizone has selected Exothera S.A. to fast-track process development of its SARS-CoV-2 vaccine for European clinical trials.

Advertisement